🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

21 recruiting trials

for Diabetic Macular Edema (DME)

Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME) NCT06942520Phase 21 site📍 Reno Sierra Eye Associates · Tests: RGX-314 Dose 1, RGX-314 Dose 2, Aflibercept (2.0 mg) Corticosteroid for Diabetic Macular Edema (DME) Study NCT07843849Phase 41 site📍 Nashville Vanderbilt University Medical Center · Tests: Intravitreal dexamethasone implant, Intravitreal dexamethasone implant A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) NCT07425522Phase 112 sites📍 Peoria📍 Beverly Hills📍 Walnut Creek Genentech, Inc. · Tests: RO7823653, Faricimab High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy NCT06662994Phase 41 site📍 Fullerton Retina Consultants of Orange County · Tests: Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321) Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales NCT06914778n/a1 site📍 Llanelli Hywel Dda Health Board · Tests: Blood draw for the laboratory assessment, Urine sample MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema NCT04187443Phase 13 sites📍 Changsha📍 Chengdu📍 Shanghai Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. · Tests: MS-553 Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant NCT06984822NA2 sites📍 Mölndal📍 Mölndal Vastra Gotaland Region · Tests: Anti-VEGF treatment, Dexamethasone implant, Treatment with intravitreal anti-VEGF OR Dexamethasone implant Kamuvudine-9 (K9) in Diabetic Macular Edema NCT07458061Phase 1, Phase 21 site📍 Roanoke Dr. Bryan Strelow · Tests: Placebo Tablet: BID, Kamuvudine K9 A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) NCT07705555Phase 333 sites📍 Gilbert📍 Glendale📍 Sacramento Merck Sharp & Dohme LLC · Tests: MK-8748, Aflibercept Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema NCT07592273Phase 2, Phase 338 sites📍 Mesa📍 Phoenix📍 Scottsdale AbbVie · Tests: Surabgene Lomparvovec, Sham, Topical Steroid, Artificial Tears Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) NCT05802329Phase 15 sites📍 Deerfield Beach📍 Erie📍 Bellaire Ocugen · Tests: OCU200 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema NCT07515079Phase 350 sites📍 Beijing📍 Beijing📍 Chongqing Bio-Thera Solutions · Tests: BAT5906 injection, Lucentis A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). NCT07867080Phase 382 sites📍 Scottsdale📍 Encino📍 Fullerton 4D Molecular Therapeutics · Tests: 4D-150 IVT (3x10^10 vg), EYELEA ® (aflibercept) Injection 2 mg (0.05mL) Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab NCT07520045NA1 site📍 Osijek Osijek University Hospital · Tests: Faricimab, Biosimilar ranibizumab DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information. NCT07308639n/a1 site📍 Leverkusen Bayer · Tests: anti-VEGF medication A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema NCT07812090Phase 21 site📍 McAllen BioAge Labs, Inc. · Tests: Oral BGE-102, Oral Placebo Matching BGE-102, Anti-VEGF, Sham Gene Therapy for DME NCT06492876Phase 1, Phase 21 site📍 Tianjin Frontera Therapeutics · Tests: FT-003 Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients NCT06929507NA2 sites📍 Alexandroupoli📍 Alexandroupoli University Hospital, Alexandroupolis · Tests: Intravitreal injection of Faricimab or Aflibercept 2 mg Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients NCT07362927EARLY Phase 12 sites📍 Shanghai📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: LX111 Injection A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005) NCT07705607Phase 319 sites📍 Waterford📍 Orlando📍 St. Petersburg Merck Sharp & Dohme LLC · Tests: MK-8748, Aflibercept A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO NCT07734844Phase 39 sites📍 Glendale📍 Pasadena📍 St. Petersburg Kodiak Sciences Inc · Tests: Tabirafusp tedromer, Aflibercept (2.0 mg)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy